ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM_BE

Venus Remedies Limited VENUSREM_BE listed on NSE and deals in

Announcements and dividends declared by Venus Remedies Limited VENUSREM_BE

Venus Remedies gets market authorisations for cancer drugs from 4 nations
Pharma major Venus Remedies on Monday said it has received market authorisations for its key cancer drugs from Philippines, Paraguay, Georgia and Moldova. With this, the company has secured 506 marketing approvals for its oncology products across 76 countr
Announcement as on 31 July 2023

Venus Remedies stops trading as sharp rally triggers enhanced surveillance measures by Sebi
SEBI recently introduced ESM framework for micro and small companies with market cap below 500 crore, leading to trading restrictions based on price variations.
Announcement as on 13 July 2023

Venus Remedies jumps 3% on nod to operate in 4 foreign markets
The company has secured 503 marketing approvals for its oncology products across 75 countries.
Announcement as on 05 July 2023

Venus Remedies hits 5% upper circuit on drug approval in Spain
The company got its approval through its German subsidiary for 500 mg, 1 g and 2 g injections of meropenem, which is used in treating skin and abdominal infections
Announcement as on 22 June 2023

Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel
The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit in Baddi, Himachal Pradesh.
Announcement as on 01 June 2023

Announcements by Venus Remedies Limited first page | Next page | Prev page |

VENUSREM_BE Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 680.92
  • 12Day Average: 712.46
  • 20Day Average: 724.03
  • 50Day Average: 744.56
  • 100Day Average: 665.03
  • 150Day Average: 569.21
  • 200Day Average: 486.17

VENUSREM_BE Indicators & signals

Indicator MACD (12,26,9)

705, 722.65, -12.59
Indicator MACD is in negative zone

Indicator ADX (14)

19.49, 16.96, 25.17
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM_BE Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Mar 2026 704.85 680.50 to 716.00 0.61% 0.35 times
05 Thu Mar 2026 700.60 664.10 to 705.00 3.75% 0.39 times
04 Wed Mar 2026 675.30 622.10 to 684.00 3.66% 0.79 times
02 Mon Mar 2026 651.45 640.00 to 668.00 -3.12% 2.01 times
27 Fri Feb 2026 672.40 664.00 to 685.00 -1.89% 0.73 times
26 Thu Feb 2026 685.35 678.50 to 698.60 -0.04% 0.45 times
25 Wed Feb 2026 685.60 674.50 to 721.10 -3.43% 2.51 times
24 Tue Feb 2026 709.95 709.95 to 747.30 -5% 1.66 times
23 Mon Feb 2026 747.30 740.25 to 769.90 -1.59% 0.31 times
20 Fri Feb 2026 759.35 741.25 to 790.00 -1.49% 0.44 times
19 Thu Feb 2026 770.80 765.00 to 804.50 -2.01% 0.69 times
18 Wed Feb 2026 786.60 749.15 to 786.60 5% 0.86 times

Videos related to: VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top